2022
Characterization and corroboration of safety signals identified from the US Food and Drug Administration Adverse Event Reporting System, 2008-19: cross sectional study
Dhodapkar MM, Shi X, Ramachandran R, Chen EM, Wallach JD, Ross JS. Characterization and corroboration of safety signals identified from the US Food and Drug Administration Adverse Event Reporting System, 2008-19: cross sectional study. The BMJ 2022, 379: e071752. PMID: 36198428, PMCID: PMC9533298, DOI: 10.1136/bmj-2022-071752.Peer-Reviewed Original ResearchConceptsPotential safety signalsSafety signalsSectional studyUS FoodDrug Administration Adverse Event Reporting SystemLiterature searchAdverse Event Reporting SystemSentinel InitiativeDrug Safety CommunicationsEvent Reporting SystemDrug safety signalsAdverse eventsCase seriesCase reportRegulatory actionDrug labelingSignificant associationFDA regulatory actionsComprehensive safety evaluationFAERSFDA
2009
Cognitive Decline among Patients with Chronic Obstructive Pulmonary Disease
Hung WW, Wisnivesky JP, Siu AL, Ross JS. Cognitive Decline among Patients with Chronic Obstructive Pulmonary Disease. American Journal Of Respiratory And Critical Care Medicine 2009, 180: 134-137. PMID: 19423714, DOI: 10.1164/rccm.200902-0276oc.Peer-Reviewed Original ResearchConceptsChronic obstructive pulmonary diseaseSevere chronic obstructive pulmonary diseaseObstructive pulmonary diseaseCognitive declinePulmonary diseaseEffect of COPDHistory of COPDPopulation-based longitudinal cohortOlder adultsSmall case seriesMultivariable mixed linear modelCognitive performanceLower cognitive performanceClinical characteristicsMultivariable adjustmentPrimary outcomeCase seriesClinical historyLongitudinal cohortActivity limitationsCognitive testingAdultsCognition scoresMean scoreStandardized measurements